Exalenz Bioscience (TASE: EXEN), a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of gastrointestinal and liver diseases, announced today Lawrence Cohen, CEO will participate in upcoming investor conferences.
The BTIG Emerging Technologies in Healthcare Diagnostics Conference taking place at the Benjamin Hotel in New York September 29 and 30th
Help employers find you! Check out all the jobs and post your resume.
